Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.

Smith HS, Buchanan J, Goranitis I, IJzerman MJ, Lavelle TA, Marshall DA, Regier DA, Ungar WJ, Weymann D, Wordsworth S, Phillips KA, Jansen JP